4/15/2014 9:35:03 AM
CAMBRIDGE, Mass., April 15, 2014 (GLOBE NEWSWIRE) -- Cerulean Pharma Inc. (Nasdaq:CERU) today announced the closing of its initial public offering of 8,500,000 shares of its common stock at a public offering price of $7.00 per share, before underwriting discounts.
Help employers find you! Check out all the jobs and post your resume.
comments powered by